Skip to Main Content

Good morning, everyone, and how are you today? We are quite busy scrambling to play catchup after a quick day away from the usual routine. The coffee kettle is fired up, though, as we concoct several cups of stimulation — we continue to favor blueberry cobbler this week — and start tackling our to-do list. Speaking of which, here are a few items of interest to help you manage your own agenda. So time to get cracking. Hope your journey is a smooth one and please do continue to keep in touch …

Democratic presidential candidates are threatening to take a controversial step that even the Obama administration rejected to lower drug prices without congressional approval, The Hill writes. The idea, known as march-in rights, involves invoking an obscure section of a 1980 law to break the patent on a drug when it is priced too high. The authority to use it has never been invoked before, but Democratic presidential candidates are increasingly embracing the idea and touting it as a concrete action they could take if they win the White House.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!